Sulopenem-Etzadroxil/Probenecid + Ciprofloxacin

Phase 3Completed
0 watching 0 views this week๐Ÿ“ˆ Rising
69
Hype Score

Development Stage

โœ“
Pre-clinical
โœ“
Phase 1
โœ“
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Uncomplicated Urinary Tract Infections

Conditions

Uncomplicated Urinary Tract Infections

Trial Timeline

Aug 1, 2018 โ†’ Jan 20, 2020

About Sulopenem-Etzadroxil/Probenecid + Ciprofloxacin

Sulopenem-Etzadroxil/Probenecid + Ciprofloxacin is a phase 3 stage product being developed by Iterum Therapeutics for Uncomplicated Urinary Tract Infections. The current trial status is completed. This product is registered under clinical trial identifier NCT03354598. Target conditions include Uncomplicated Urinary Tract Infections.

Hype Score Breakdown

Clinical
27
Activity
18
Company
2
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT03354598Phase 3Completed

Competing Products

13 competing products in Uncomplicated Urinary Tract Infections

See all competitors